<DOC>
	<DOC>NCT02786810</DOC>
	<brief_summary>The study will be evaluating the efficacy and safety of a contrast drug in pediatric renal ultrasound.</brief_summary>
	<brief_title>Contrast Enhanced Ultrasound for Evaluation of Reflux Nephropathy</brief_title>
	<detailed_description />
	<mesh_term>Gastroesophageal Reflux</mesh_term>
	<mesh_term>Urinary Tract Infections</mesh_term>
	<mesh_term>Vesico-Ureteral Reflux</mesh_term>
	<criteria>Informed consent Age more than or equal to 8 years Patient with history of urinary tract infection (UTI) and history of Voiding Cystourethrogram (VCUG) for vesicoureteral reflux Candidate for Dimercaptosuccinic acid (DMSA) scan or scan for renal scar Demonstration of renal scarring by DMSA scan or renal ultrasound without contrast Includes healthy volunteers Age less than 8years Allergy to contrast or related products Cardiac shunt/ congenital heart anomalies Abnormal baseline ECG Open heart surgery Evidence of retinopathy Patient in intensive care Unable to comply with study requirement History of emphysema Unable to maintain oxygen saturation of 92% on at room air Pregnancy and lactation</criteria>
	<gender>All</gender>
	<minimum_age>8 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>